iPROLEPSIS (@iprolepsis) header
iPROLEPSIS (@iprolepsis) profile picture

🏥 iPROLEPSIS: Psoriatic arthritis inflammation explained through multi-source data analysis guiding a novel personalized digital care ecosystem⚕️

Joined January 2023
Photo by iPROLEPSIS (@iprolepsis)Photo by iPROLEPSIS (@iprolepsis)Photo by iPROLEPSIS (@iprolepsis)Photo by iPROLEPSIS (@iprolepsis)Photo by iPROLEPSIS (@iprolepsis)Photo by iPROLEPSIS (@iprolepsis)Photo by iPROLEPSIS (@iprolepsis)Photo by iPROLEPSIS (@iprolepsis)Photo by iPROLEPSIS (@iprolepsis)Photo by iPROLEPSIS (@iprolepsis)
How can AI, biomarkers and digital health support personalised disease prevention? Join the @iprolepsis & CARE-IN-HEALTH webinar to explore chronic inflammation and the health-to-disease transition. 📅 30 Nov | 13:00–15:30 CET | Online Register: forms.cloud.microsoft/pages/…
2
1
63
How can AI, biomarkers and digital health support personalised disease prevention? Join the @iprolepsis & CARE-IN-HEALTH webinar to explore chronic inflammation and the health-to-disease transition. 📅 30 Nov | 13:00–15:30 CET | Online 🔗 Register: forms.cloud.microsoft/pages/…
2
1
36
How can AI, biomarkers and digital health support personalised disease prevention? Join the @iprolepsis & CARE-IN-HEALTH webinar to explore chronic inflammation and the health-to-disease transition. 📅 30 Nov | 13:00–15:30 CET | Online 🔗 Register: forms.cloud.microsoft/pages/…
2
15
An important milestone for @iprolepsis: the first participant has been enrolled in the iPROLEPSIS-PPIDC study. The study compares a personalised intervention on food, physical activity and stress with usual care in people with PsA. iprolepsis.eu/clinical-studi… #psoriaticarthritis
1
58
🗞️ The 13th @iprolepsis Newsletter is now available. This edition features World Psoriasis Day activities, updates on the HPOS and IDBV studies, recent publications, Learning Hub resources and project events. iprolepsis.eu/_files/ugd/981… #PsoriaticArthritis #DigitalHealth
1
34
Prof. Leontios Hadjileontiadis (AUTH), coordinator of @iprolepsis, presented the project’s paper on wearable-derived heart rate variability and inflammation in psoriatic arthritis at IEEE WF-IoT 2026 in Abu Dhabi. #iPROLEPSIS #PsoriaticArthritis
2
70
iPROLEPSIS retweeted
Can the way we type on a phone reveal signs of Parkinson’s disease? Prof. Leontios Hadjileontiadis (AUTH), coordinator of @aiprognosis and @iprolepsis, talks about both projects on Homo sAIence, voria.gr’s AI vidcast (in Greek). youtube.com/watch?v=qLZdsT5w…
1
1
2
69
Today is #WorldPsoriasisDay. Up to 30% of people with psoriasis may develop psoriatic arthritis, which can affect many aspects of everyday life. Explore the @iprolepsis Learning Hub for reliable information and resources: iprolepsis.eu/learning-hub-n… #LookBeyondMySkin #psoriasis
🤖 Made with AI
34
Today is #WorldPsoriasisDay. Up to 30% of people with psoriasis may develop psoriatic arthritis, which can affect many aspects of everyday life. Explore the @iprolepsis Learning Hub for reliable information and resources: iprolepsis.eu/learning-hub-n… #LookBeyondMySkin
🤖 Made with AI
1
36
World Psoriasis Day is tomorrow. Do you have psoriasis? We need your support. @Hippocrates_IMI HPOS study is open to adults with psoriasis in participating European countries who have not been diagnosed with psoriatic arthritis. #WorldPsoriasisDay #LookBeyondMySkin #Psoriasis
1
3
182
Find out if you are eligible and register for HPOS: hpos.study
1
15
HPOS participants who meet the eligibility criteria may also be eligible for the @iprolepsis IDBV Study. It explores whether information from a smartphone could help researchers detect early changes linked to #psoriaticarthritis. Learn more: iprolepsis.eu/idbv
5
World Psoriasis Day is tomorrow. Do you have psoriasis? We need your support. @Hippocrates_IMI HPOS study is open to adults with psoriasis in participating European countries who have not been diagnosed with psoriatic arthritis. #WorldPsoriasisDay #LookBeyondMySkin #Psoriasis
1
28
Find out if you are eligible and register for HPOS: hpos.study/
1
11
HPOS participants who meet the eligibility criteria may also be eligible for the @iprolepsis IDBV Study. It explores whether information from a smartphone could help researchers detect early changes linked to #psoriaticarthritis. Learn more: iprolepsis.eu/idbv
7